<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Care and caution are required in using <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> to combat sight-threatening ocular disease </plain></SENT>
<SENT sid="1" pm="."><plain>Informed consent of the patient and the active participation of a knowledgeable internist are mandatory in view of the known potential consequences of therapy </plain></SENT>
<SENT sid="2" pm="."><plain>These consequences or side effects include specific and general problems, and before initiating therapy the cost/benefit ratio must be considered </plain></SENT>
<SENT sid="3" pm="."><plain>Although the most commonly used agents are nonspecific, some drugs appear more beneficial in certain conditions than others, as is the case of <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>It is a policy at the <z:hpo ids='HP_0000554'>Uveitis</z:hpo> Clinic of the University of California, Irvine, to institute immunosuppressive therapy early enough for conservation of useful vision, yet late enough so that it is clear that moderate to heavy steroid therapy cannot prevent <z:hpo ids='HP_0000618'>blindness</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the event of failure of the "conventional" immunosuppressive therapy, plasmapheresis may prove a helpful adjunct </plain></SENT>
</text></document>